COVID-19 and organ transplant recipients, risk factors and considerations: A mini-review

Abstract

The emergence of coronavirus 2 is distinctive and created an unprecedented obstacle in the entire history of organ transplantation. Transplant patients are more susceptible to COVID-19 infection due to various medical comorbidities and immunosuppressive therapy. The mortality rate was also reported as up to 30% in transplant patients. The fundamental implications of COVID-19 are different depending on the organ transplanted and the receiver's comorbidities. In addition to this, non-pharmacological interventions and vaccines help prevent COVID-19 in transplant patients. In this mini-review, we focused on summarizing current literature associated with transplant patients with COVID-19 infection, clinical outcomes, risk factors, and precautions to be taken during the pandemic.